Nabriva Therapeutics PLC (OTC Pink - Limited Information:NBRVF)
| 0.45 Delayed Data As of Sep 29 |  +0.03 / +7.14%Today’s Change | 0.37 Today|||52-Week Range 2.87 | -76.19% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Assets | Cash | 75.3M | 100.3M | 102.0M | 91.0M | |
| Short Term Investment Cash | -14.0M | 24.6M | 1.5M | -11.0M | ||
| Cash & Short Term Investments | 75.5M | 100.7M | 102.2M | 91.3M | ||
| Receivables | Receivables | 8.3M | 8.9M | 5.4M | 8.2M | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Prepaid Expenses | 1.2M | 1.2M | 1.2M | 973.0K | |
| Current Assets | 84.9M | 110.7M | 108.8M | 100.5M | ||
| Total Assets | Property, Plant and Equipment - Gross | -- | -- | 4.6M | -- | |
| Depreciation | -- | -- | -3.5M | -- | ||
| Intangible Assets | 127.0K | 109.0K | 98.0K | 99.0K | ||
| Other Assets | 127.0K | 109.0K | 98.0K | 99.0K | ||
| Total Assets | 86.8M | 112.4M | 110.4M | 104.0M | ||
| Liabilities | Accounts Payable | 2.9M | 4.8M | 3.3M | 7.6M | |
| Other Current Liabilities | 4.6M | 5.4M | 7.1M | 5.9M | ||
| Other Liabilities | 11.3M | 15.1M | 17.8M | 18.1M | ||
| Total Liabilities | Long Term Debt | 592.0K | 710.0K | 23.7M | 23.9M | |
| Other Liabilities | 236.0K | 244.0K | 264.0K | 1.8M | ||
| Total Liabilities | 12.1M | 16.0M | 41.8M | 43.9M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 74.7M | 96.4M | 68.6M | 60.1M | ||
| Total Shareholder Equity | 74.7M | 96.4M | 68.6M | 60.1M | ||
| Share Information | Common Shares Outstanding | 41.0M | 66.5M | 67.0M | 71.3M | |
| Addtl. Info. | No data currently available for this section. | |||||
